Skip to main content
OpenTrials
Completed

NCT Number: NCT01811147

Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI

The purpose of the study is to find out what parts of the brain have increased or decreased activity and connectivity in individuals who have bipolar disorder, major depression, or no history of mood disorder. Another purpose of this study is to use MRI images to determine which young adults with major depression may be at greater risk for developing mild or more severe symptoms of mania which suggests a diagnosis of bipolar disorder.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Cleveland Clinic Foundation Center for Behavioral Health

Cleveland, Ohio, 44195, United States

About this study

The study involves two phases, phase one includes the screening visit and MRI. The second phase, for depression participants, involves in person follow ups for up to two years. The second phase, for healthy and bipolar participants, involves phone follow ups, every three months for up to two years. The purpose of this study is listed above. We plan to enroll 200 participants total.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

FOR BIPOLAR DEPRESSED PATIENTS:

  • Ages 15 - 30 years (inclusive) and able to give voluntary informed consent (parents must also sign consent for subjects under 18)
  • Satisfy criteria for Diagnostic and Statistical Manual 4th edition (DSM-IV-TR) for Bipolar I or II disorder
  • Satisfy criteria for DSM-IV depressive episode-current
  • 17-item Hamilton Depression Rating Scale > 15 but < 25;
  • Young Mania Rating Scale score < 10
  • Satisfy criteria to undergo an MRI scan based on MRI screening questionnaire.
  • Able to be managed as outpatients during the study as ascertained by the following - i. Clinical Global Severity Scale < 5 i.e. moderately ill; ii. No significant suicidal or homicidal ideation or grossly disabled.

Inclusion criteria

FOR ALL UNIPOLAR DEPRESSED PATIENTS:

  • Ages 15 - 30 years and able to give voluntary informed consent (Parental consent must also be obtained for those under 18 years old).
  • Satisfy criteria for DSM-IV-TR Major Depressive Episode using a Structured Interview
  • Never met criteria for mania or hypomania
  • 17-item Hamilton Depression Rating Scale score (HDRS) > 15 and < 25.
  • Young Mania Rating Scale (YMRS) score < 10
  • Satisfy safety criteria to undergo an MRI scan
  • Able to be managed as outpatients during the study as ascertained by the following - i. Clinical Global Severity Scale < 5 i.e. moderately ill; ii. No significant suicidal or homicidal ideation or grossly disabled

ADDITIONAL INCLUSION CRITERIA FOR HIGH RISK UD (HRUD) PATIENTS BESIDE THE INCLUSION CRITERIA FOR UD:

At least one of the following:

  • Family history of bipolar disorder in at least one first degree relative
  • History of any sub-threshold hypomania symptoms
  • History of mood episode related psychotic symptoms

ADDITIONAL INCLUSION CRITERIA FOR LOW RISK UD (HRUD) PATIENTS BESIDE THE INCLUSION CRITERIA FOR UD:

  • No family history of BD in a first or a second degree relative
  • No past history of any sub-threshold hypomania symptoms
  • No history of psychotic symptoms

Exclusion criteria

FOR DEPRESSION AND BIPOLAR SUBJECTS:

  • Meeting DSM-IV criteria for schizophrenia, schizophreniform disorder, schizoaffective disorder, mental retardation, pervasive developmental disorder.
  • History of receiving electroconvulsive therapy in the past 1 year
  • Use of neuroleptics, mood stabilizers or benzodiazepines in the past 2 weeks.
  • Use of antidepressants in the past 2 weeks.
  • If on fluoxetine in the past, then should not have been on this medication for 5 weeks.
  • Acutely suicidal or homicidal or requiring inpatient treatment.
  • Meeting DSM-IV criteria for other substance/alcohol dependence within the past 6 months or abuse in the past 3 months, excluding caffeine or nicotine. The criteria will be evaluated by interview and urinary toxicology screening. The use of caffeine or nicotine will be recorded.
  • Use of alcohol in the past 1 week before the MRI scan.
  • No serious acute or chronic medical or neurological illness, including previously known HIV positive status (due to possible CNS involvement) as assessed by history, physical examination and laboratory examination including EKG, CBC and blood chemistry.
  • Current pregnancy or breast feeding.
  • Metallic implants or other contraindication to MRI.

Inclusion criteria

FOR HEALTHY CONTROLS: Healthy subjects matched for age, gender and ethnicity will be included

  • Ages 15 - 30 years (inclusive) and able to give voluntary informed consent (Parental consent must also be obtained for those under 18 years old)
  • No current or past history of psychiatric illness or substance abuse or dependence.
  • No current or past history of psychiatric illness or substance abuse or dependence in a first degree relative.

Exclusion criteria

FOR HEALTHY CONTROLS:

  • Pregnant or breast feeding.
  • Metallic implants or other contraindication to MRI.
  • Significant family history of psychiatric or neurological illness.
  • Currently taking any prescription or centrally acting medications.
  • Serious acute or chronic medical or neurological illness as assessed by history, physical examination and laboratory examination including CBC and blood chemistry.
  • Use of alcohol in the past 1 week and not being able to avoid alcohol use during the course of the study.

Treatment and study plan

Selective serotonin reuptake inhibitor (SSRI)

Drug

Subjects with depression will be treated with a Selective Serotonin Reuptake Inhibitor (SSRI) or a Serotonin-norepinephrine reuptake inhibitor (SNRI) for 24 months.

Other names: Serotonin-norepinephrine reuptake inhibitor

Primary outcomes

  1. HAM-D 17 Item: Hamilton Depression Rating Scale

    Time frame: 24 months

    Hamilton depression rating scale (17-item HAM-D):

    Scores can range from 0 to 52: No depression (0-7); Mild depression (8-16); Moderate depression (17-23); and Severe depression (≥24).

Secondary outcomes

  1. YMRS: Young Mania Rating Scale

    Time frame: 24 months

    Young Mania Rating Scale: Scores can range from 0 to 60: In Remission/No Mania (0-8); Mild (9-12); Moderate (13-18); Severe (19-25); Very Severe (>25)

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Registry information

Important dates

Study start
2011
Primary completion
2018
Study completion
2018
First posted
Mar 14, 2013
Registry last updated
Dec 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.